Guide (PDF) Lithium-Ion Battery Technology Development
PDF | Lithium-ion batteries (LIBs), as the core of modern energy storage technology, have profoundly reshaped human society''s understanding
Guide From Present Innovations to Future Potential: The Promising
Advances in material science and electrode engineering, coupled with rising demand for high-performance rechargeable batteries, underscore the importance of continuous research and
Guide Evaluation of the relevance of DILI predictive hypotheses in early drug
Several studies have shown total administered dose alone or in combination with drug lipophilicity to be correlated with a higher risk of DILI. However, it would be best to have a predictive DILI methodology
Guide DILI prediction in drug development: present and future
Idiosyncratic drug-induced liver injury (iDILI) results in significant patient morbidity and significantly increases the risk of drug development. The
Guide Managing the challenge of drug-induced liver injury: a roadmap
Current preclinical models poorly predict the potential of a new drug candidate to cause drug-induced liver injury (DILI) in humans. Here, Park and colleagues discuss current understanding
Guide ReCell Center
The ReCell Center also utilizes Crosscutting Activities that benefit the center''s efforts more broadly. The Center''s research and development projects are evaluated using Argonne''s EverBatt model. This
Guide Advancing energy storage: The future trajectory of lithium-ion battery
These efforts collectively contribute to the overarching goal of developing cost-effective lithium-ion battery solutions, as discussed in these insightful research papers.
Guide Improved Detection of Drug-Induced Liver Injury by Integrating
Drug-induced liver injury (DILI) has been a significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals. Over the last decade, the existing
Guide Overview of Mechanisms of Drug-Induced Liver Injury (DILI) and Key
New drugs with DILI potential are usually identified in preclinical and premarketing clinical development due to the vigilance of regulatory bodies and Industry. DILI imposes major clinical,
Guide Development of A Battery of In Silico Prediction Tools for Drug
Drug-induced liver injury (DILI) remains a major challenge in drug development, regulation, and safety assessment, especially when translating pre-clinical stage knowledge to human clinical studies or
Guide (PDF) Development of A Battery of In Silico Prediction Tools for Drug
The purpose of our study is to investigate which are the key molecular fingerprints that may cause DILI risk, and then to obtain a reliable ensemble model to predict DILI risk with these key factors.
Guide New approach methodologies (NAMs) for drug-induced liver injury
To enable objective and systematic assessment of NAMs, we propose DILIference, a curated reference drug list compiled from the literature to guide the development and benchmarking
Guide Study of Waste Generation and Composition in the Capital of Dili, Dili
The research conducted in the Capital of Dili in 4 (four) Sub-District such as; Cristo Rei, Dom Aleixo, Nain Feto and Vera Cruz.
Guide Causality Assessment for Suspected DILI During Clinical Phases of
Causality assessment is a critical step in establishing the diagnosis of drug induced liver injury (DILI) during drug development. DILI may resemble almost any type of liver disease, and often
Guide Challenges in speeding up solid-state battery development
Solid-state batteries are widely regarded as one of the next promising energy storage technologies. Here, Wolfgang Zeier and Juergen Janek review recent research directions and
Guide Evaluation of DILI Predictive Hypotheses in Early Drug Development
Drug-induced liver injury (DILI) is a leading cause of drug failure in clinical trials and a major reason for drug withdrawals. DILI has been shown to be dependent on both daily dose and extent of hepatic
Guide Key Challenges and Opportunities Associated with the
Many private and public initiatives have invested extensive efforts toward the development of research tools for the early and safe prediction of human DILI.
Guide Dili Energy Storage Battery Agent: Powering Renewable Energy
Summary: As global demand for stable renewable energy grows, Dili energy storage battery agents have become critical components in solar farms, wind parks, and industrial microgrids. This article
Guide A review of challenges and prospects of 3D cell-based culture
Drug-induced liver injury (DILI) is the leading cause of compound attrition during drug development. Over the years, a battery of in-vitro cell culture toxicity tests is being conducted to evaluate the
Guide CIOMS: Drug-induced liver injury, DILI
Suggested citation: Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting. A consensus by a CIOMS Working Group.
Guide Batteries
Research supported by TTO led to today''s modern nickel metal hydride batteries, which nearly all first generation hybrid electric vehicles used. Similarly, the
Guide Batteries
Batteries articles from across Nature Portfolio Atom RSS Feed A battery is a device that stores energy in chemical form and can convert it into electric energy through electrochemical reactions.
Guide MIP-DILI | IHI Innovative Health Initiative
Development of a battery of preclinical test systems for detecting DILI, which are fit for purpose. Determination of what can – and what cannot – be predicted with current DILI test systems in order
Guide CIOMS: Drug-induced liver injury, DILI
The CIOMS Working Group on Drug-Induced Liver Injury was established to provide a balanced and global perspective on DILI detection, susceptibility factors and outcome, advise on causality
Guide Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for
The diagnosis and management of drug-induced liver injury (DILI) remains a challenge in clinical trials in drug development. The qualification of emerging biomarkers capable of predicting
Guide Svensk forskning för hållbar tillväxt| RISE
Vi bidrar till snabbare omställning och stärkt konkurrenskraft för företagen, samhället och Sverige.
Guide Development of a Battery of In Silico Prediction Tools for Drug
Our approach in this comparative analysis is to leverage existing preclinical and clinical data as well as information on metabolism to better translate mammalian to human DILI.